Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
데이터 추가 비고
원인
The symbiq pump touchscreen may not respond to user selection may experience a delayed response or may register a different value from the value selected by the user. failure of the touchscreen to respond to user input could result in a delay in therapy or result in over delivery of medication if the user does not confirm the intended programmed values on the pump's.